The microscopic organisms living in our intestines may influence the severity of COVID-19 and the body’s immune response to it, and could account for lingering symptoms, researchers reported on Monday in the journal Gut. They found that the gut microorganisms in COVID-19 patients were very different from those in uninfected individuals. “COVID patients lack certain…
Tag: Covid Treatments
FOX11 reports “Studies suggest 4 vitamins to lower risk of severe cases of COVID-19”
We’ve learned a lot the past year about how to fight COVID-19. The latest studies show an arsenal in your medicine cabinet could be quite simple, in the form of vitamins. After dozens of studies have recently shown the importance of Vitamin D when fighting COVID-19, Dr. Peter Osborne with Origins Nutrition Center suggests, you consider…
Corman-Drosten Review Report reports “External peer review of the RTPCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results”
The published RT-qPCR protocol for detection and diagnostics of 2019-nCoV and the manuscript suffer from numerous technical and scientific errors, including insufficient primer design, a problematic and insufficient RT-qPCR protocol, and the absence of an accurate test validation. Neither the presented test nor the manuscript itself fulfils the requirements for an acceptable scientific publication. Further,…
Evolution of Medicine reports “Covid Antifragility: Trusting Our Strength in Uncertain Times”
Are we as vulnerable to Covid as public health authorities want us to believe? Instead of focusing on our weakness, we should be focusing on becoming more resilient and antifragile. In various states in America, governors have placed stringent restrictions upon the celebration of holidays, going so far as to dictate how long our celebrations…
Forbes reports “Antiviral Drug Remdesivir Proves Ineffective In Treating Covid-19, WHO Study Finds”
The antiviral drug remdesivir had little or no effect in treating patients hospitalized with Covid-19, according to a study that has not yet been peer reviewed, but was coordinated by the World Health Organization and released on Thursday, casting doubt on one of the few promising treatments for the coronavirus. Remdesivir is the only specific drug…
Real Clear Politics reports “The Tragic Hydroxychloroquine Debate and Dr. Fauci’s Denial of Evidence”
As an epidemiologist trained to make causal inference, especially from observations, I feel strongly that there is an urgent need for an open and honest debate on the ability of hydroxychloroquine (HCQ) to save lives. I had not paid much attention to discussions related to the efficacy of pharmacological interventions in the treatment of Covid-19…
Medscape reports “Paul Offit’s Biggest Concern About COVID Vaccines”
Topol: Well, that gets us to the public trust and the fact that willingness to have the vaccine is important. Because if there is terrible mistrust, we won’t ever get to the level of immunity in the population. Offit: It’s hard to promote trust now absent data. Once we know the characteristics of these vaccines, it’ll be…
USA Today reports “‘We’re not your slaves’: Alternative health providers bristle at warning letters about their coronavirus treatments”
Operation Quack Hack, the federal government’s initiative to clamp down on fake coronavirus medications and cures, has exposed a health underground in America brimming with distrust not only of mainstream medicine but the government itself. It’s a Tea Party for COVID-times. Its members are angry at government warning letters that many perceive as an infringement on…
Jennifer Margulis reports “Natural Treatments for Coronavirus”
Naturopathic doctors and Chinese medicine practitioners have natural treatments for coronavirus. These remedies have been tremendously successful. But when doctors share their COVID-19 treatment protocols with their patients, via private email lists or in articles posted on the web, they’re being shut down by government censors.
Stat News reports “The U.S. government contributed research to a Gilead Remdesivir patent — but didn’t get credit”
Two documents dating back to 2015 shed further light on the role the federal government played in discovering remdesivir and its use in treating coronaviruses — work that has taken on new meaning as the Gilead Sciences (GILD) drug has gained global attention and an emergency use authorization from federal regulators to treat patients with…